"As the field of cardio-oncology has grown, there is increasing awareness of the risk of other potential cardiotoxicities, including concerns regarding accelerated hypertension, vascular disease and arrhythmias with some newer chemotherapeutic agents."
(4-6) Presumably, PRES observed in AIP is secondary to the accelerated hypertension that may be observed as part of the autonomic hyperactivity of AIP.